Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

229.53
Delayed Data
As of Sep 04
 +1.06 / +0.46%
Today’s Change
111.41
Today|||52-Week Range
263.81
+60.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues2.1B2.3B2.2B2.7B
 
 
 
 
 
Cost of Goods Sold514.6M537.1M532.9M635.5M
 
 
 
 
 
Depreciation And Amortization406.9M434.3M407.0M635.0M
 
 
 
 
 
 
Operating ExpensesGross Income1.1B1.3B1.3B1.5B
 
 
 
 
 
General Expenses563.2M583.6M629.6M766.6M
 
 
 
 
 
Other Operating Expenses0.000.006.1M176.9M
 
 
 
Research And Development59.1M59.1M55.8M81.1M
 
 
 
 
 
Total Operating Expenses1.5B1.6B1.6B2.2B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income571.5M725.0M615.3M518.4M
 
 
 
 
 
Extraordinary Credit--28.9M0.000.00
 
 
Extraordinary Charge-140.0M-138.7M-91.9M-176.9M
 
 
 
 
 
Interest Expense On Debt258.4M223.7M297.8M412.7M
 
 
 
 
 
Other Expenses202.8M198.6M-71.1M5.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income376.7M590.1M155.4M-64.7M
 
 
 
 
 
Income Taxes-100.3M-56.0M-80.9M-13.1M
 
 
 
 
 
Minority Interest-1.0M-800.0K-800.0K-1.4M
 
 
 
 
 
Net Income275.4M534.9M73.7M-53.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS335.4M335.8M336.8M344.4M
 
 
 
 
 
Shares To Calculate EPS Diluted341.3M341.9M343.4M344.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.82$1.59$0.22-$0.15
 
 
 
 
 
EPS Diluted$0.81$1.56$0.21-$0.15